• Conference Recording
  • On-Demand
  • Practice Management
This session covers the employer health benefit landscape and how it has changed over the last five years due to COVID, new treatments, technology, and competition.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Treatment Strategies
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.   
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Treatment Strategies
Obesity has emerged as a global epidemic with significant repercussions for public health due to its strong relationship with diseases such as from insulin resistance, Type 2 diabetes, hypertension
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
The session will begin by providing a general overview of the prevalence and epidemiology of nonalcoholic fatty liver disease.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pediatrics
  • Pharmacotherapy
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.   
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Behavioral Modification
Incretin medications, like semaglutide and tirzepatide, suppress appetite and delay gastric emptying, facilitating weight loss and begging the question of the need for concurrent behavior change th
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
  • Pediatrics
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.   
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Practice Management
In this session, co-presented by a primary care and an obesity-focused tertiary care provider, we will review barriers and facilitators to pediatric obesity treatment in primary and tertiary care s
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Practice Management
70% of Americans have pre-obesity or the serious, chronic, and relapsing disease of obesity.
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Treatment Strategies
This lecture explores the relationship between endocrine disruptors and their potential role in obesity.
  • 1.00 AMA PRA Category 1 Credit

Pages